title: Role of transforming growth factor-beta in cancer progression.
abstract: Invasion and metastasis are the most lethal characteristics of cancer and the leading causes of cancer-related death. Transforming growth factor (TGF)-beta is a multifunctional cytokine that normally functions to prevent the uncontrolled proliferation of epithelial, endothelial and hematopoietic cells. Quite dichotomously, however, aberrant genetic or epigenetic events often negate the cytostatic function of TGF-beta in these cells, leading to tumor formation. Once freed from the growth-inhibitory effects of TGF-beta, cancer cells acquire the ability to proliferate, invade and metastasize when stimulated by TGF-beta. A thorough understanding of the molecular mechanisms underlying these paradoxical functions of TGF-beta remains elusive. Here, the authors review the tumor-suppressing and -promoting activities of TGF-beta and discuss the potential use and targeting of the TGF-beta-signaling system to prevent the progression and acquisition of metastatic phenotypes by human malignancies.
authors.affiliation: University of Colorado Health Sciences Center, Department of Pharmacology, Aurora, Colorado 80045, USA.
authors.forename: Amy J
authors.initials: AJ
authors.lastname: Galliher
authors.forename: Jason R
authors.initials: JR
authors.lastname: Neil
authors.forename: William P
authors.initials: WP
authors.lastname: Schiemann
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology; D018450:Disease Progression; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D009385:Neoplastic Processes; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000503:physiopathology; D015398:Signal Transduction; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D016212:Transforming Growth Factor beta